Subscribe free

Wounds ·

Customized bacteriophage therapy effectively cures chronic wounds and promotes healing

A randomized, placebo-controlled, double-blind clinical trial evaluated the efficacy and safety of bacteriophage therapy for chronic wounds. Customized bacteriophage cocktails were applied to wounds, resulting in 93.3% becoming sterile in 39 days, followed by complete healing within 90 days. In contrast, 83.3% of wounds treated with placebo remained colonized by bacteria without healing. The study concludes that customized bacteriophage therapy effectively cures chronic wounds regardless of patient characteristics, such as age, sex, diabetes, or multidrug-resistant bacteria infection.

Journal Article by Karn SL, Bhartiya SK (…) Nath G et 5 al. in Int J Low Extrem Wounds

read the whole article in Int J Low Extrem Wounds

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in Wounds.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in Wounds

The latest stitches

JAMA Surg4 Sep 2026

Incisional Negative Pressure Wound Therapy Reduces SSIs

In a systematic review of 85 trials, incisional negative pressure wound therapy (INPWT) significantly lowered the risk of overall surgical site infections (SSIs) and related wound complications compared to standard dressings.

All papers in Wounds →